JALMARTI
LIVE

Serial Number

79341028

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

JALMARTI Trademark

Serial Number: 79341028 • Registration: 6959600

JALMARTI is a trademark filed by NOVARTIS AG on March 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 8, 2022

Registration Date

January 24, 2023

Published for Opposition

November 8, 2022

Goods & Services

Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

INTERNATIONAL REGISTRATION RENEWED
Feb 14, 2025 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
May 23, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 3, 2023 FICS
FINAL DISPOSITION PROCESSED
May 3, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 24, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 24, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 24, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2022 CNSA
REFUSAL PROCESSED BY IB
Oct 2, 2022 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 2, 2022 RFCS
REFUSAL PROCESSED BY MPU
Sep 1, 2022 RFRR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2022 TROA
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 3, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 2, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 2, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 11, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 6, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
May 19, 2022 SDRC